Kardioprotektion durch Candesartan bei Herzinsuffizienz: CHARM-overall-Teilauswertung (Candesartan in heart failure assessment of reduction in mortality and morbidity)

Author： Tschöpe C.   Schultheiss H.  

Publisher： Springer Publishing Company

ISSN： 0020-9554

Source： Der Internist, Vol.47, Iss.10, 2006-10, pp. : 1084-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) Study Programme

By SWEDBERG K.   PFEFFER M.   GRANGER G. B.   McMURRAY J.   YUSUF S.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 60-60

Informa Healthcare

Access to resources Recommend Favorite

Current and future uses of candesartan in the treatment of heart failure

By McKelvie Robert S  

Future Cardiology, Vol. 2, Iss. 4, 2006-07 ,pp. : 391-402

Future Medicine

Access to resources Recommend Favorite

Angiotensinrezeptorblocker bei Herzinsuffizienz: CHARM-Studie

By  

Der Internist, Vol. 45, Iss. 9, 2004-09 ,pp. : 1063-1067

Springer Publishing Company

Access to resources Recommend Favorite

Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate

By Minatoguchi Shinya   Aoyama Takuma   Kawai Naoki   Iwasa Mitsunori   Oda Masayuki   Kida Keiji   Kojima Syojiro   Goto Naomi   Goto Masahiro   Sugishita Fusayoshi   Takai Kuniyuki   Tanaka Ryuhei   Hiei Keiji   Minagawa Taro   Yamamoto Noritaka   Watanabe Ikuo   Yasue Takao   Kobayashi Hiroshi  

Blood Pressure, Vol. 22, Iss. 1, 2013-09 ,pp. : 29-37

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil vs Losartan

By BUNT TON  

Blood Pressure, Vol. 7, Iss. 4, 1998-11 ,pp. : 253-253

Informa Healthcare

Access to resources Recommend Favorite